Drugs / TRIBENZOIN
TRIBENZOIN
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05938452 | Dec 2022 → Oct 2023 | nervous system disorder | Forest Hills Lab | Completed | No outcome recorded |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TRIBENZOIN | ChEMBL registry synonym — accepted as the source's own label CHEMBL6068549 ↗ |
| Known as | Benzoflex s 404 | ChEMBL registry synonym — accepted as the source's own label CHEMBL6068549 ↗ |
| Known as | FEMA NO. 3398 | ChEMBL registry synonym — accepted as the source's own label CHEMBL6068549 ↗ |
| Known as | Glyceryl Tribenzoate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05938452 ↗ |
| Known as | GTB | “Safety and Tolerability of Glyceryl Tribenzoate (GTB) Capsules in Healthy Subjects” NCT05938452 ↗ |
| Known as | NSC-2230 | ChEMBL registry synonym — accepted as the source's own label CHEMBL6068549 ↗ |
| Known as | Uniplex 260 | ChEMBL registry synonym — accepted as the source's own label CHEMBL6068549 ↗ |
| Modality | Small molecule | — CHEMBL6068549 ↗ |
| Route | Oral | “Oral Solution” NCT05938452 ↗ |